Subject(s)
COVID-19 , Occupational Stress/etiology , Physicians/psychology , Adaptation, Psychological , Adult , Aged , Burnout, Professional , Female , Humans , Male , Middle Aged , Morale , Nursing Staff, Hospital/psychology , Pandemics , Personal Protective Equipment , Physician-Patient Relations , Professional-Family Relations , Surveys and Questionnaires , Telemedicine , Visitors to PatientsABSTRACT
Coronavirus disease 2019 (COVID-19) is an infection caused by the severe acute respiratory syndrome-coronavirus-2 virus that led to a pandemic. Acute manifestations of COVID-19 include fever, cough, dyspnea, respiratory failure, pneumonitis, anosmia, thromboembolic events, cardiogenic shock, renal injury, ischemic strokes, encephalitis, and cutaneous eruptions, especially of hands or feet. Prolonged symptoms, unpredictable recoveries, and chronic sequelae (long COVID) sometimes emerge even for some people who survive the initial illness. Sequelae such as fatigue occasionally persist even for those with only mild to moderate cases. There is much to learn about postacute COVID-19 dyspnea, anosmia, psychosis, thyroiditis, cardiac arrhythmia, and/or multisystem inflammatory response syndrome in children. Determining prognoses is imprecise. Examining patient databases about those who have survived COVID-19 is warranted. Multidisciplinary teams are assessing such disease databases to better understand longer-term complications and guide treatment.
Subject(s)
COVID-19/complications , COVID-19/epidemiology , Comorbidity , Humans , Incidence , Pandemics , Prognosis , SARS-CoV-2 , Post-Acute COVID-19 SyndromeSubject(s)
Antidepressive Agents/adverse effects , Arrhythmias, Cardiac/chemically induced , COVID-19 Drug Treatment , Depressive Disorder/drug therapy , Heart Diseases/physiopathology , Antiviral Agents/adverse effects , Arrhythmias, Cardiac/etiology , Atrial Fibrillation/physiopathology , Atrioventricular Block/chemically induced , Bundle-Branch Block/chemically induced , COVID-19/physiopathology , Chloroquine/adverse effects , Depressive Disorder/physiopathology , Humans , Hydroxychloroquine/adverse effects , Long QT Syndrome/chemically induced , Torsades de Pointes/chemically inducedSubject(s)
Coronavirus Infections , Disease Transmission, Infectious/prevention & control , Mental Disorders , Pandemics , Pneumonia, Viral , Betacoronavirus/isolation & purification , COVID-19 , Communicable Disease Control/methods , Comorbidity , Coronavirus Infections/epidemiology , Coronavirus Infections/psychology , Coronavirus Infections/therapy , Humans , Mental Disorders/diagnosis , Mental Disorders/epidemiology , Pneumonia, Viral/epidemiology , Pneumonia, Viral/psychology , Pneumonia, Viral/therapy , SARS-CoV-2 , Social Isolation/psychology , Social SupportABSTRACT
The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) causes the coronavirus disease 2019 (COVID-19). It quickly became pandemic, and so did a new concern about COVID-19 infections increasing the risk for cerebrovascular diseases. There is an association between COVID-19 illness in people and acute stroke. Several chemical, mechanical, and/or inflammatory central nervous system pathologies are proposed to explain how this viral infection might induce acute cerebrovascular disease. Timely available evaluation and/or intervention is imperative for patients with concerns about acute cerebrovascular issues.